{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:57:13Z","timestamp":1792025833577,"version":"4.4.0"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10304-w","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T11:23:31Z","timestamp":1738668211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Growth hormone signaling and clinical implications: from molecular to therapeutic perspectives"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5022-2224","authenticated-orcid":false,"given":"Zahra Sadat","family":"Aghili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golnoosh","family":"Khoshnevisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rezvan","family":"Mostoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Alibaglouei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7720-4859","authenticated-orcid":false,"given":"Sayyed Hamid","family":"Zarkesh-Esfahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"10304_CR1","first-page":"35","volume":"1","author":"A Bayol","year":"2004","unstructured":"Bayol A, Bristow A, Charton E, Girard M, Jongen P (2004) Somatropin and its variants: structural characterization and methods of analysis. Pharmeuropa Bio 1:35\u201345","journal-title":"Pharmeuropa Bio"},{"issue":"2\u20133","key":"10304_CR2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ghir.2014.01.005","volume":"24","author":"DC P\u00e9rez-Ibave","year":"2014","unstructured":"P\u00e9rez-Ibave DC, Rodr\u00edguez-S\u00e1nchez IP, de Lourdes Garza-Rodr\u00edguez M, Barrera-Salda\u00f1a HA (2014) Extrapituitary growth hormone synthesis in humans. Growth Hormon IGF Res 24(2\u20133):47\u201353","journal-title":"Growth Hormon IGF Res"},{"issue":"5","key":"10304_CR3","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1210\/en.2018-00037","volume":"159","author":"S Liao","year":"2018","unstructured":"Liao S, Vickers MH, Stanley JL, Baker PN, Perry JK (2018) Human placental growth hormone variant in pathological pregnancies. Endocrinology 159(5):2186\u20132198","journal-title":"Endocrinology"},{"key":"10304_CR4","first-page":"85","volume-title":"Growth hormone","author":"VS Bonert","year":"2017","unstructured":"Bonert VS, Melmed S (2017) Growth hormone. Elsevier, The Pituitary, pp 85\u2013127"},{"issue":"2","key":"10304_CR5","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/j.2040-4603.2016.tb00692.x","volume":"6","author":"FJ Steyn","year":"2016","unstructured":"Steyn FJ, Tolle V, Chen C, Epelbaum J (2016) Neuroendocrine regulation of growth hormone secretion. Compr Physiol 6(2):687\u2013735","journal-title":"Compr Physiol"},{"issue":"8","key":"10304_CR6","first-page":"MC13","volume":"8","author":"N Khatib","year":"2014","unstructured":"Khatib N, Gaidhane S, Gaidhane AM, Khatib M, Simkhada P, Gode D et al (2014) Ghrelin: ghrelin as a regulatory peptide in growth hormone secretion. J Clin Diagn Research: JCDR 8(8):MC13","journal-title":"J Clin Diagn Research: JCDR"},{"issue":"2","key":"10304_CR7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1210\/er.2018-00216","volume":"40","author":"MH Aguiar-Oliveira","year":"2019","unstructured":"Aguiar-Oliveira MH, Bartke A (2019) Growth hormone deficiency: health and longevity. Endocr Rev 40(2):575\u2013601","journal-title":"Endocr Rev"},{"issue":"10","key":"10304_CR8","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.3390\/cells10102664","volume":"10","author":"S Al-Samerria","year":"2021","unstructured":"Al-Samerria S, Radovick S (2021) The role of insulin-like growth factor-1 (IGF-1) in the control of neuroendocrine regulation of growth. Cells 10(10):2664","journal-title":"Cells"},{"issue":"02","key":"10304_CR9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/a-0822-3637","volume":"51","author":"M Xatzipsalti","year":"2019","unstructured":"Xatzipsalti M, Voutetakis A, Stamoyannou L, Chrousos GP, Kanaka-Gantenbein C (2019) Congenital hypopituitarism: various genes, various phenotypes. Horm Metab Res 51(02):81\u201390","journal-title":"Horm Metab Res"},{"key":"10304_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000341733","volume":"23","author":"RE Bancalari","year":"2012","unstructured":"Bancalari RE, Gregory LC, McCabe MJ, Dattani MT (2012) Pituitary gland development: an update. Endocr Dev 23:1\u201315","journal-title":"Endocr Dev"},{"issue":"11","key":"10304_CR11","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.earlhumdev.2009.08.057","volume":"85","author":"KS Alatzoglou","year":"2009","unstructured":"Alatzoglou KS, Dattani MT (2009) Genetic forms of hypopituitarism and their manifestation in the neonatal period. Early Hum Dev 85(11):705\u2013712","journal-title":"Early Hum Dev"},{"issue":"6","key":"10304_CR12","doi-asserted-by":"crossref","first-page":"e2103","DOI":"10.1210\/clinem\/dgz184","volume":"105","author":"LC Gregory","year":"2020","unstructured":"Gregory LC, Dattani MT (2020) The molecular basis of congenital hypopituitarism and related disorders. J Clin Endocrinol Metabolism 105(6):e2103\u2013e20","journal-title":"J Clin Endocrinol Metabolism"},{"key":"10304_CR13","first-page":"91","volume-title":"Growth hormone","author":"VS Herman-Bonert","year":"2022","unstructured":"Herman-Bonert VS, Melmed S (2022) Growth hormone. Elsevier, The pituitary, pp 91\u2013129"},{"issue":"45","key":"10304_CR14","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1556\/650.2019.31507","volume":"160","author":"T Halmos","year":"2019","unstructured":"Halmos T, Suba I (2019) [The physiological role of growth hormone and insulin-like growth factors]. Orv Hetil 160(45):1774\u20131783","journal-title":"Orv Hetil"},{"key":"10304_CR15","doi-asserted-by":"crossref","unstructured":"Babaniyi GG, Akor UJ, Babaniyi EE (2024) GH\u2013IGF-1 Axis and Hypothalamic\u2013Pituitary\u2013Testicular Axis in Drug Development. Perspectives of Quorum quenching in New Drug Development. CRC, pp 167\u2013186","DOI":"10.1201\/9781003297826-9"},{"key":"10304_CR16","doi-asserted-by":"crossref","first-page":"597573","DOI":"10.3389\/fendo.2020.597573","volume":"11","author":"GJ Strous","year":"2020","unstructured":"Strous GJ, Almeida ADS, Putters J, Schantl J, Sedek M, Slotman JA et al (2020) Growth hormone receptor regulation in cancer and chronic diseases. Front Endocrinol 11:597573","journal-title":"Front Endocrinol"},{"key":"10304_CR17","doi-asserted-by":"crossref","first-page":"297357","DOI":"10.3389\/fendo.2018.00035","volume":"9","author":"F Dehkhoda","year":"2018","unstructured":"Dehkhoda F, Lee CM, Medina J, Brooks AJ (2018) The growth hormone receptor: mechanism of receptor activation, cell signaling, and physiological aspects. Front Endocrinol 9:297357","journal-title":"Front Endocrinol"},{"issue":"1","key":"10304_CR18","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, Li J, Fu M, Zhao X, Wang W (2021) The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Therapy 6(1):402","journal-title":"Signal Transduct Target Therapy"},{"issue":"5","key":"10304_CR19","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4049\/jimmunol.178.5.2623","volume":"178","author":"PJ Murray","year":"2007","unstructured":"Murray PJ (2007) The JAK-STAT signaling pathway: input and output integration. J Immunol 178(5):2623\u20132629","journal-title":"J Immunol"},{"issue":"7","key":"10304_CR20","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3390\/ijms19071843","volume":"19","author":"M W\u00f3jcik","year":"2018","unstructured":"W\u00f3jcik M, Krawczy\u0144ska A, Antushevich H, Herman AP (2018) Post-receptor inhibitors of the GHR-JAK2-STAT pathway in the growth hormone signal transduction. Int J Mol Sci 19(7):1843","journal-title":"Int J Mol Sci"},{"key":"10304_CR21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ghir.2015.09.002","volume":"28","author":"C Carter-Su","year":"2016","unstructured":"Carter-Su C, Schwartz J, Argetsinger LS (2016) Growth hormone signaling pathways. Growth Hormon IGF Res 28:11\u201315","journal-title":"Growth Hormon IGF Res"},{"issue":"7","key":"10304_CR22","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3390\/ph5070758","volume":"5","author":"D Mirecki-Garrido","year":"2012","unstructured":"Mirecki-Garrido D, Guerra B, Mateos-D\u00edaz C, Jim\u00e9nez-Monz\u00f3n R, D\u00edaz-Chico N, D\u00edaz-Chico JC et al (2012) The influence of estrogens on the biological and therapeutic actions of growth hormone in the liver. Pharmaceuticals 5(7):758\u2013778","journal-title":"Pharmaceuticals"},{"issue":"17","key":"10304_CR23","doi-asserted-by":"crossref","first-page":"8283","DOI":"10.7150\/thno.61192","volume":"11","author":"J Liu","year":"2021","unstructured":"Liu J, Nie C, Xue L, Yan Y, Liu S, Sun J et al (2021) Growth hormone receptor disrupts glucose homeostasis via promoting and stabilizing retinol binding protein 4. Theranostics 11(17):8283","journal-title":"Theranostics"},{"key":"10304_CR24","doi-asserted-by":"crossref","first-page":"110999","DOI":"10.1016\/j.mce.2020.110999","volume":"518","author":"SJ Frank","year":"2020","unstructured":"Frank SJ (2020) Classical and novel GH receptor signaling pathways. Mol Cell Endocrinol 518:110999","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"10304_CR25","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrendo.2010.123","volume":"6","author":"AJ Brooks","year":"2010","unstructured":"Brooks AJ, Waters MJ (2010) The growth hormone receptor: mechanism of activation and clinical implications. Nat Reviews Endocrinol 6(9):515\u2013525","journal-title":"Nat Reviews Endocrinol"},{"key":"10304_CR26","doi-asserted-by":"crossref","unstructured":"Freund T (2015) Hepatocellular alterations and dysregulation of oncogenic pathways in the liver of transgenic mice overexpressing growth hormone: Dissertation, Albert-Ludwigs-Universit\u00e4t Freiburg,; 2015","DOI":"10.17160\/josha.2.4.40"},{"issue":"2","key":"10304_CR27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ymgme.2006.10.006","volume":"90","author":"TI Cese\u00f1a","year":"2007","unstructured":"Cese\u00f1a TI, Cui TX, Piwien-Pilipuk G, Kaplani J, Calinescu A-A, Huo JS et al (2007) Multiple mechanisms of growth hormone-regulated gene transcription. Mol Genet Metab 90(2):126\u2013133","journal-title":"Mol Genet Metab"},{"issue":"41","key":"10304_CR28","doi-asserted-by":"crossref","first-page":"25951","DOI":"10.1074\/jbc.272.41.25951","volume":"272","author":"J Liao","year":"1997","unstructured":"Liao J, Hodge C, Meyer D, Ho PS, Rosenspire K, Schwartz J (1997) Growth hormone regulates ternary complex factors and serum response factor associated with the c-fos serum response element. J Biol Chem 272(41):25951\u201325958","journal-title":"J Biol Chem"},{"issue":"4","key":"10304_CR29","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1210\/me.2010-0232","volume":"25","author":"TX Cui","year":"2011","unstructured":"Cui TX, Lin G, LaPensee CR, Calinescu A-A, Rathore M, Streeter C et al (2011) C\/EBP\u03b2 mediates growth hormone-regulated expression of multiple target genes. Mol Endocrinol 25(4):681\u2013693","journal-title":"Mol Endocrinol"},{"key":"10304_CR30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fendo.2018.00035","volume":"9","author":"F Dehkhoda","year":"2018","unstructured":"Dehkhoda F, Lee CM, Medina J, Brooks AJ (2018) The growth hormone receptor: mechanism of receptor activation, cell signaling, and physiological aspects. Front Endocrinol 9:35","journal-title":"Front Endocrinol"},{"key":"10304_CR31","doi-asserted-by":"crossref","first-page":"111075","DOI":"10.1016\/j.mce.2020.111075","volume":"520","author":"Y Chhabra","year":"2021","unstructured":"Chhabra Y, Lee CM, M\u00fcller AF, Brooks AJ (2021) GHR signalling: receptor activation and degradation mechanisms. Mol Cell Endocrinol 520:111075","journal-title":"Mol Cell Endocrinol"},{"issue":"3\u20134","key":"10304_CR32","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/08977194.2018.1518324","volume":"36","author":"EM Linossi","year":"2018","unstructured":"Linossi EM, Calleja DJ, Nicholson SE (2018) Understanding SOCS protein specificity. Growth Factors 36(3\u20134):104\u2013117","journal-title":"Growth Factors"},{"issue":"6790","key":"10304_CR33","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/35016611","volume":"405","author":"D Metcalf","year":"2000","unstructured":"Metcalf D, Greenhalgh CJ, Viney E, Willson TA, Starr R, Nicola NA et al (2000) Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 405(6790):1069\u20131073","journal-title":"Nature"},{"issue":"5","key":"10304_CR34","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1096\/fj.201802328R","volume":"33","author":"Y Chhabra","year":"2019","unstructured":"Chhabra Y, Nelson CN, Plescher M, Barclay JL, Smith AG, Andrikopoulos S et al (2019) Loss of growth hormone\u2013mediated signal transducer and activator of transcription 5 (STAT5) signaling in mice results in insulin sensitivity with obesity. FASEB J 33(5):6412","journal-title":"FASEB J"},{"issue":"1","key":"10304_CR35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00223-019-00636-8","volume":"108","author":"K Kritmetapak","year":"2021","unstructured":"Kritmetapak K, Kumar R (2021) Phosphate as a signaling molecule. Calcif Tissue Int 108(1):16\u201331","journal-title":"Calcif Tissue Int"},{"key":"10304_CR36","doi-asserted-by":"crossref","first-page":"613069","DOI":"10.3389\/fimmu.2020.613069","volume":"11","author":"A Adamo","year":"2021","unstructured":"Adamo A, Frusteri C, Pallotta MT, Pirali T, Sartoris S, Ugel S (2021) Moonlighting proteins are important players in cancer immunology. Front Immunol 11:613069","journal-title":"Front Immunol"},{"issue":"11","key":"10304_CR37","first-page":"1263","volume":"7","author":"M Bielohuby","year":"2014","unstructured":"Bielohuby M, Zarkesh-Esfahani SH, Manolopoulou J, Wirthgen E, Walpurgis K, Toghiany Khorasgani M et al (2014) Validation of serum IGF-I as a biomarker to monitor the bioactivity of exogenous growth hormone agonists and antagonists in rabbits. Dis Models Mech 7(11):1263\u20131273","journal-title":"Dis Models Mech"},{"issue":"6","key":"10304_CR38","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1159\/000527123","volume":"95","author":"BS Miller","year":"2022","unstructured":"Miller BS, Rogol AD, Rosenfeld RG (2022) The history of the insulin-like growth factor system. Hormone Res Paediatrics 95(6):619\u2013630","journal-title":"Hormone Res Paediatrics"},{"issue":"7","key":"10304_CR39","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1016\/j.clnu.2021.04.021","volume":"40","author":"CZ Watling","year":"2021","unstructured":"Watling CZ, Kelly RK, Tong TY, Piernas C, Watts EL, Tin ST et al (2021) Associations of circulating insulin-like growth factor-I with intake of dietary proteins and other macronutrients. Clin Nutr 40(7):4685\u20134693","journal-title":"Clin Nutr"},{"key":"10304_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-10-224","volume":"10","author":"JE Puche","year":"2012","unstructured":"Puche JE, Castilla-Cort\u00e1zar I (2012) Human conditions of insulin-like growth factor-I (IGF-I) deficiency. J Translational Med 10:1\u201329","journal-title":"J Translational Med"},{"issue":"6","key":"10304_CR41","doi-asserted-by":"crossref","first-page":"R212","DOI":"10.1530\/EC-18-0099","volume":"7","author":"WF Blum","year":"2018","unstructured":"Blum WF, Alherbish A, Alsagheir A, El Awwa A, Kaplan W, Koledova E et al (2018) The growth hormone\u2013insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders. Endocr Connections 7(6):R212\u2013R22","journal-title":"Endocr Connections"},{"issue":"5","key":"10304_CR42","doi-asserted-by":"crossref","first-page":"C954","DOI":"10.1152\/ajpcell.00598.2008","volume":"296","author":"PM Yamada","year":"2009","unstructured":"Yamada PM, Lee K-W (2009) Perspectives in mammalian IGFBP-3 biology: local vs. systemic action. Am J Physiology-Cell Physiol 296(5):C954\u2013C76","journal-title":"Am J Physiology-Cell Physiol"},{"issue":"20","key":"10304_CR43","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1158\/1078-0432.CCR-07-4879","volume":"14","author":"MM Chitnis","year":"2008","unstructured":"Chitnis MM, Yuen JS, Protheroe AS, Pollak M, Macaulay VM (2008) The type 1 insulin-like growth factor receptor pathway. Clin Cancer Res 14(20):6364\u20136370","journal-title":"Clin Cancer Res"},{"key":"10304_CR44","doi-asserted-by":"crossref","first-page":"e81286","DOI":"10.7554\/eLife.81286","volume":"11","author":"J Li","year":"2022","unstructured":"Li J, Wu J, Hall C, Bai X-c, Choi E (2022) Molecular basis for the role of disulfide-linked \u03b1CTs in the activation of insulin-like growth factor 1 receptor and insulin receptor. Elife 11:e81286","journal-title":"Elife"},{"issue":"12","key":"10304_CR45","doi-asserted-by":"crossref","first-page":"a008987","DOI":"10.1101\/cshperspect.a008987","volume":"5","author":"MJ Wagner","year":"2013","unstructured":"Wagner MJ, Stacey MM, Liu BA, Pawson T (2013) Molecular mechanisms of SH2-and PTB-domain-containing proteins in receptor tyrosine kinase signaling. Cold Spring Harb Perspect Biol 5(12):a008987","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"10304_CR46","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s12035-021-02611-7","volume":"59","author":"M Kumar","year":"2022","unstructured":"Kumar M, Bansal N (2022) Implications of phosphoinositide 3-kinase-akt (PI3K-Akt) pathway in the pathogenesis of Alzheimer\u2019s disease. Mol Neurobiol 59(1):354\u2013385","journal-title":"Mol Neurobiol"},{"key":"10304_CR47","unstructured":"Murray PG, Clayton PE (2015) Disorders of growth hormone in childhood"},{"issue":"19","key":"10304_CR48","doi-asserted-by":"crossref","first-page":"11069","DOI":"10.3390\/ijms231911069","volume":"23","author":"J Smyczy\u0144ska","year":"2022","unstructured":"Smyczy\u0144ska J, Pawelak N, Hilczer M, Lewi\u0144ski A (2022) Delayed diagnosis of congenital combined pituitary hormone Deficiency including severe growth hormone Deficiency in children with persistent neonatal hypoglycemia\u2014case reports and review. Int J Mol Sci 23(19):11069","journal-title":"Int J Mol Sci"},{"issue":"06","key":"10304_CR49","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jped.2021.02.007","volume":"97","author":"ABW Tavares","year":"2021","unstructured":"Tavares ABW, Collett-Solberg PF (2021) Growth hormone deficiency and the transition from pediatric to adult care. Jornal De Pediatria 97(06):595\u2013602","journal-title":"Jornal De Pediatria"},{"issue":"2","key":"10304_CR50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1530\/EJE-21-1179","volume":"187","author":"E Laurer","year":"2022","unstructured":"Laurer E, Sirovina A, Blaschitz A, Tischlinger K, Montero-Lopez R, Hoertenhuber T et al (2022) The landscape of retesting in childhood-onset idiopathic growth hormone deficiency and its reversibility: a systematic review and meta-analysis. Eur J Endocrinol 187(2):265\u2013278","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10304_CR51","doi-asserted-by":"crossref","first-page":"206","DOI":"10.23736\/S0026-4946.20.05821-1","volume":"72","author":"JG Halas","year":"2020","unstructured":"Halas JG, Grimberg A (2020) Dilemmas of growth hormone treatment for GH deficiency and idiopathic short stature: defining, distinguishing, and deciding. Minerva Pediatr 72(3):206","journal-title":"Minerva Pediatr"},{"issue":"4","key":"10304_CR52","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3390\/endocrines3040060","volume":"3","author":"C O\u2019Neill","year":"2022","unstructured":"O\u2019Neill C, Gangat M, Radovick S (2022) Growth hormone deficiency. Endocrines 3(4):736\u2013744","journal-title":"Endocrines"},{"issue":"1","key":"10304_CR53","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s43042-024-00480-y","volume":"25","author":"TH Ammar","year":"2024","unstructured":"Ammar TH, Al-Ettribi GM, Abo Hashish MM, Farid TM, Abou-Elalla AA, Thomas MM (2024) Screening of GHSR, GHRHR, GH1 genes in isolated growth hormone deficiency disease in Egyptian patients. Egypt J Med Hum Genet 25(1):16","journal-title":"Egypt J Med Hum Genet"},{"key":"10304_CR54","doi-asserted-by":"crossref","unstructured":"\u00d6zt\u00fcrk AP, Aslanger AD, Bas F, Toksoy G, Karaman V, Bagirova G et al (2023) Phenotype-genotype correlations of GH1 gene variants in patients with isolated growth hormone deficiency (IGHD) or multiple pituitary hormone deficiency (MPHD). Hormone research in paediatrics","DOI":"10.1159\/000531113"},{"issue":"12","key":"10304_CR55","doi-asserted-by":"crossref","first-page":"e251897","DOI":"10.1136\/bcr-2022-251897","volume":"15","author":"V Gasco","year":"2022","unstructured":"Gasco V, Matarazzo P, De Sanctis L, Ghigo E (2022) Growth hormone deficiency in a case of septo-optic-dysplasia due to SOX2 mutation: should we re-test patients during the transition period? BMJ Case Rep CP 15(12):e251897","journal-title":"BMJ Case Rep CP"},{"issue":"suppl1","key":"10304_CR56","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1530\/EJE-07-0156","volume":"157","author":"D Kelberman","year":"2007","unstructured":"Kelberman D, Dattani MT (2007) Hypothalamic and pituitary development: novel insights into the aetiology. Eur J Endocrinol 157(suppl1):S3\u2013S14","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10304_CR57","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/cen.14608","volume":"96","author":"G Binder","year":"2022","unstructured":"Binder G, H\u00e4hnel J, Weber K, Schweizer R (2022) Adult height after treatment of neurosecretory dysfunction and comparison to idiopathic GHD. Clin Endocrinol 96(2):184\u2013189","journal-title":"Clin Endocrinol"},{"key":"10304_CR58","doi-asserted-by":"crossref","first-page":"108575","DOI":"10.1016\/j.ijscr.2023.108575","volume":"109","author":"MM Al-Salihi","year":"2023","unstructured":"Al-Salihi MM, Qassim T, Aji N, Al-Jebur MS, Rahman MM, Ayyad A (2023) The clinical aspects of septo-optic dysplasia: a narrative review with illustrative case report. Int J Surg Case Rep 109:108575","journal-title":"Int J Surg Case Rep"},{"issue":"5","key":"10304_CR59","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1515\/jpem-2022-0538","volume":"36","author":"C Sethuraman","year":"2023","unstructured":"Sethuraman C, Venkatasamy S (2023) Clinical profile of Laron dwarfism\u2013experience from a tertiary care institute in Chennai. J Pediatr Endocrinol Metab 36(5):466\u2013469","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10304_CR60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11154-020-09595-0","volume":"22","author":"Z Laron","year":"2021","unstructured":"Laron Z, Werner H (2021) Laron syndrome\u2013a historical perspective. Reviews Endocr Metabolic Disorders 22:31\u201341","journal-title":"Reviews Endocr Metabolic Disorders"},{"issue":"3","key":"10304_CR61","doi-asserted-by":"crossref","first-page":"313","DOI":"10.59249\/TCAA2040","volume":"96","author":"RMK Shabbir","year":"2023","unstructured":"Shabbir RMK, Nalbant G, Zaman Q, Tolun A, Malik S, Mumtaz S, Focus (2023) Big Data: a recurrent mutation in growth hormone receptor (GHR) gene underlying Laron-type dwarfism in a Pakistani family. Yale J Biol Med 96(3):313","journal-title":"Yale J Biol Med"},{"issue":"2","key":"10304_CR62","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrendo.2016.138","volume":"13","author":"EL Wakeling","year":"2017","unstructured":"Wakeling EL, Brioude F, Lokulo-Sodipe O, O\u2019Connell SM, Salem J, Bliek J et al (2017) Diagnosis and management of silver\u2013Russell syndrome: first international consensus statement. Nat Reviews Endocrinol 13(2):105\u2013124","journal-title":"Nat Reviews Endocrinol"},{"issue":"1","key":"10304_CR63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-5-19","volume":"5","author":"T Eggermann","year":"2010","unstructured":"Eggermann T, Begemann M, Binder G, Spengler S (2010) Silver-Russell syndrome: genetic basis and molecular genetic testing. Orphanet J Rare Dis 5(1):1\u20138","journal-title":"Orphanet J Rare Dis"},{"key":"10304_CR64","unstructured":"Roberts AE (2022) Noonan syndrome"},{"issue":"11","key":"10304_CR65","first-page":"999","volume":"53","author":"JM Ko","year":"2008","unstructured":"Ko JM, Kim J-M, Kim G-H, Yoo H-W (2008) PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype\u2013phenotype correlation in Korean patients with Noonan syndrome. J Hum Genet 53(11):999\u20131006","journal-title":"J Hum Genet"},{"key":"10304_CR66","doi-asserted-by":"crossref","unstructured":"Saint-Laurent C, Mazeyrie L, Yart A, Edouard T (2023) Novel therapeutic perspectives in Noonan syndrome and RASopathies. Eur J Pediatrics.:1\u20139","DOI":"10.1007\/s00431-023-05263-y"},{"issue":"9","key":"10304_CR67","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/humrep\/dev158","volume":"30","author":"J Mao","year":"2015","unstructured":"Mao J, Xu H, Wang X, Huang B, Liu Z, Zhen J et al (2015) Congenital combined pituitary hormone deficiency patients have better responses to gonadotrophin-induced spermatogenesis than idiopathic hypogonadotropic hypogonadism patients. Hum Reprod 30(9):2031\u20132037","journal-title":"Hum Reprod"},{"issue":"13","key":"10304_CR68","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.3390\/cells11132088","volume":"11","author":"A Sertedaki","year":"2022","unstructured":"Sertedaki A, Tatsi EB, Vasilakis IA, Fylaktou I, Nikaina E, Iacovidou N et al (2022) Whole exome sequencing points towards a multi-gene synergistic action in the pathogenesis of congenital combined pituitary hormone deficiency. Cells 11(13):2088","journal-title":"Cells"},{"key":"10304_CR69","doi-asserted-by":"crossref","unstructured":"Backeljauw P, Chernausek SD, Gravholt CH, Kruszka P (2021) Turner syndrome. Sperling Pediatric Endocrinology.:627\u2013\u200960","DOI":"10.1016\/B978-0-323-62520-3.00017-8"},{"issue":"1","key":"10304_CR70","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.yapd.2022.03.004","volume":"69","author":"M Steiner","year":"2022","unstructured":"Steiner M, Saenger P (2022) Turner syndrome: an update. Adv Pediatr 69(1):177\u2013202","journal-title":"Adv Pediatr"},{"issue":"6","key":"10304_CR71","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1210\/clinem\/dgac082","volume":"107","author":"C H\u00f6ybye","year":"2022","unstructured":"H\u00f6ybye C, Tauber M (2022) Approach to the patient with prader\u2013Willi Syndrome. J Clin Endocrinol Metabolism 107(6):1698\u20131705","journal-title":"J Clin Endocrinol Metabolism"},{"key":"10304_CR72","doi-asserted-by":"crossref","unstructured":"Mao S, Yang L, Gao Y, Zou C (2024) Genotype\u2013phenotype correlation in Prader-Willi syndrome: a large\u2010sample analysis in China. Clin Genet","DOI":"10.1111\/cge.14477"},{"key":"10304_CR73","unstructured":"Zacharia SS (2022) Endocrine dysfunction in patients with moderate to severe traumatic Brain Injury 6 months to 2 years after Injury. Christian Medical College, Vellore"},{"key":"10304_CR74","doi-asserted-by":"crossref","first-page":"634415","DOI":"10.3389\/fendo.2021.634415","volume":"12","author":"V Gasco","year":"2021","unstructured":"Gasco V, Cambria V, Bioletto F, Ghigo E, Grottoli S (2021) Traumatic brain injury as frequent cause of hypopituitarism and growth hormone deficiency: epidemiology, diagnosis, and treatment. Front Endocrinol 12:634415","journal-title":"Front Endocrinol"},{"key":"10304_CR75","unstructured":"Variant N (2018) Growth Disorders. Pediatric Endocrinology: A Practical Clinical Guide.:2"},{"issue":"5","key":"10304_CR76","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.2016.19699","volume":"317","author":"ME Molitch","year":"2017","unstructured":"Molitch ME (2017) Diagnosis and treatment of pituitary adenomas: a review. JAMA 317(5):516\u2013524","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10304_CR77","first-page":"1","volume":"59","author":"KH Darzy","year":"2003","unstructured":"Darzy KH, Shalet SM (2003) Radiation-induced growth hormone deficiency. Horm Res 59(Suppl 1):1\u201311","journal-title":"Horm Res"},{"key":"10304_CR78","doi-asserted-by":"crossref","unstructured":"Lorca VAB, Wu S (2024) Growth hormone and radiation therapy: friend, foe, or both? Endocrine-related Cancer.;31(3)","DOI":"10.1530\/ERC-22-0371"},{"issue":"6","key":"10304_CR79","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1210\/clinem\/dgac747","volume":"108","author":"L Das","year":"2023","unstructured":"Das L, Dutta P (2023) Approach to the patient: a case with an unusual cause of hypopituitarism. J Clin Endocrinol Metabolism 108(6):1488\u20131504","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"5","key":"10304_CR80","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11910-023-01263-5","volume":"23","author":"TL Wexler","year":"2023","unstructured":"Wexler TL (2023) Neuroendocrine disruptions following head injury. Curr Neurol Neurosci Rep 23(5):213\u2013224","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"12","key":"10304_CR81","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJMra1713301","volume":"378","author":"ES Husebye","year":"2018","unstructured":"Husebye ES, Anderson MS, K\u00e4mpe O (2018) Autoimmune polyendocrine syndromes. N Engl J Med 378(12):1132\u20131141","journal-title":"N Engl J Med"},{"issue":"1","key":"10304_CR82","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EJE-09-0044","volume":"161","author":"GJ Kahaly","year":"2009","unstructured":"Kahaly GJ (2009) Polyglandular autoimmune syndromes. Eur J Endocrinol 161(1):11\u201320","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10304_CR83","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000452150","volume":"86","author":"A Grimberg","year":"2017","unstructured":"Grimberg A, DiVall SA, Polychronakos C, Allen DB, Cohen LE, Quintos JB et al (2017) Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Hormone Res Paediatrics 86(6):361\u2013397","journal-title":"Hormone Res Paediatrics"},{"key":"10304_CR84","doi-asserted-by":"crossref","unstructured":"Ram\u00edrez-Renter\u00eda C, Hern\u00e1ndez-Ram\u00edrez LC (2024) Genetic diagnosis in acromegaly and gigantism: from research to clinical practice. Best Practice & Research Clinical Endocrinology & Metabolism, p 101892","DOI":"10.1016\/j.beem.2024.101892"},{"issue":"12","key":"10304_CR85","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41574-018-0114-1","volume":"14","author":"A Beckers","year":"2018","unstructured":"Beckers A, Petrossians P, Hanson J, Daly AF (2018) The causes and consequences of pituitary gigantism. Nat Reviews Endocrinol 14(12):705\u2013720","journal-title":"Nat Reviews Endocrinol"},{"key":"10304_CR86","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ghir.2016.08.002","volume":"30","author":"F Hannah-Shmouni","year":"2016","unstructured":"Hannah-Shmouni F, Trivellin G, Stratakis CA (2016) Genetics of gigantism and acromegaly. Growth Hormon IGF Res 30:37\u201341","journal-title":"Growth Hormon IGF Res"},{"issue":"4","key":"10304_CR87","first-page":"559","volume":"89","author":"I Raus","year":"2016","unstructured":"Raus I, Coroiu RE (2016) McCune Albright syndrome-association of fibrous dysplasia, caf\u00e9-au-lait skin spots and hyperthyroidism\u2013case report. Clujul Med 89(4):559","journal-title":"Clujul Med"},{"key":"10304_CR88","first-page":"197","volume-title":"McCune\u2013Albright syndrome, and GH-producing tumors","author":"E Peverelli","year":"2021","unstructured":"Peverelli E, Treppiedi D, Mangili F, Catalano R, Mantovani G, GNAS (2021) McCune\u2013Albright syndrome, and GH-producing tumors. Elsevier, Gigantism and Acromegaly, pp 197\u2013223"},{"key":"10304_CR89","doi-asserted-by":"crossref","first-page":"934748","DOI":"10.3389\/fendo.2022.934748","volume":"13","author":"K Takedani","year":"2022","unstructured":"Takedani K, Yamamoto M, Kanasaki K (2022) ACTH-independent Cushing\u2019s syndrome due to ectopic endocrinologically functional adrenal tissue caused by a GNAS heterozygous mutation: a rare case of McCune\u2013Albright syndrome accompanied by central amenorrhea and hypothyroidism: a case report and literature review. Front Endocrinol 13:934748","journal-title":"Front Endocrinol"},{"key":"10304_CR90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-1-1","volume":"1","author":"F Marini","year":"2006","unstructured":"Marini F, Falchetti A, Monte FD, Sala SC, Gozzini A, Luzi E et al (2006) Multiple endocrine neoplasia type 1. Orphanet J Rare Dis 1:1\u20139","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10304_CR91","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/endrev\/bnaa031","volume":"42","author":"ML Brandi","year":"2021","unstructured":"Brandi ML, Agarwal SK, Perrier ND, Lines KE, Valk GD, Thakker RV (2021) Multiple endocrine neoplasia type 1: latest insights. Endocr Rev 42(2):133\u2013170","journal-title":"Endocr Rev"},{"issue":"50","key":"10304_CR92","doi-asserted-by":"crossref","first-page":"e8999","DOI":"10.1097\/MD.0000000000008999","volume":"96","author":"Q Liu","year":"2017","unstructured":"Liu Q, Tong D, Liu G, Yi Y, Zhang D, Zhang J et al (2017) Carney complex with PRKAR1A gene mutation: a case report and literature review. Medicine 96(50):e8999","journal-title":"Medicine"},{"issue":"02\/03","key":"10304_CR93","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1055\/a-0753-4943","volume":"127","author":"CD Kamilaris","year":"2019","unstructured":"Kamilaris CD, Faucz FR, Voutetakis A, Stratakis CA (2019) Carney complex. Exp Clin Endocrinol Diabetes 127(02\/03):156\u2013164","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"8","key":"10304_CR94","doi-asserted-by":"crossref","first-page":"T77","DOI":"10.1530\/ERC-20-0015","volume":"27","author":"V Vasilev","year":"2020","unstructured":"Vasilev V, Daly AF, Trivellin G, Stratakis CA, Zacharieva S, Beckers A (2020) Hereditary endocrine tumours: current state-of-the-art and research opportunities: the roles of AIP and GPR101 in familial isolated pituitary adenomas (FIPA). Endocrine-related Cancer 27(8):T77\u2013T86","journal-title":"Endocrine-related Cancer"},{"issue":"2","key":"10304_CR95","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1210\/er.2012-1013","volume":"34","author":"A Beckers","year":"2013","unstructured":"Beckers A, Aaltonen LA, Daly AF, Karhu A (2013) Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocr Rev 34(2):239\u2013277","journal-title":"Endocr Rev"},{"key":"10304_CR96","doi-asserted-by":"crossref","unstructured":"Honegger J (2019) Pituitary Surgery. Advanced Practice in Endocrinology Nursing.:415\u2013\u200932","DOI":"10.1007\/978-3-319-99817-6_22"},{"issue":"3","key":"10304_CR97","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.yfrne.2013.07.005","volume":"34","author":"M Theodoropoulou","year":"2013","unstructured":"Theodoropoulou M, Stalla GK (2013) Somatostatin receptors: from signaling to clinical practice. Front Neuroendocrinol 34(3):228\u2013252","journal-title":"Front Neuroendocrinol"},{"issue":"3","key":"10304_CR98","first-page":"351","volume":"41","author":"M Mercado","year":"2015","unstructured":"Mercado M, Espinosa E, Ramirez C (2015) Current status and future directions of pharmacological therapy for acromegaly. Minerva Endocrinol 41(3):351\u2013365","journal-title":"Minerva Endocrinol"},{"key":"10304_CR99","doi-asserted-by":"crossref","unstructured":"Fainstein-Day P, Ullmann TE, Dalurzo MCL, Sevlever GE, Smith DE (2024) The clinical and biochemical spectrum of ectopic acromegaly. Best Practice & Research Clinical Endocrinology & Metabolism, p 101877","DOI":"10.1016\/j.beem.2024.101877"},{"issue":"3","key":"10304_CR100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3390\/pathophysiology30030029","volume":"30","author":"CP Daniel","year":"2023","unstructured":"Daniel CP, Wagner MJ, Borne GE, Plaisance CJ, Ahmadzadeh S, Aquino A et al (2023) Acromegaly: pathophysiological considerations and treatment options including the evolving role of oral somatostatin analogs. Pathophysiology 30(3):377\u2013388","journal-title":"Pathophysiology"},{"key":"10304_CR101","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fendo.2018.00469","volume":"9","author":"O Cooper","year":"2018","unstructured":"Cooper O, Greenman Y (2018) Dopamine agonists for pituitary adenomas. Front Endocrinol 9:469","journal-title":"Front Endocrinol"},{"key":"10304_CR102","doi-asserted-by":"crossref","first-page":"101319","DOI":"10.1016\/j.ghir.2020.101319","volume":"52","author":"JA Janssen","year":"2020","unstructured":"Janssen JA (2020) Mechanisms of putative IGF-I receptor resistance in active acromegaly. Growth Hormon IGF Res 52:101319","journal-title":"Growth Hormon IGF Res"},{"key":"10304_CR103","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2165\/11318510-000000000-00000","volume":"69","author":"RA Feelders","year":"2009","unstructured":"Feelders RA, Hofland LJ, van Aken MO, Neggers SJ, Lamberts SW, de Herder WW et al (2009) Medical therapy of acromegaly: efficacy and safety of somatostatin analogues. Drugs 69:2207\u20132226","journal-title":"Drugs"},{"issue":"6","key":"10304_CR104","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0300-2977(01)00171-1","volume":"59","author":"CA Heijckmann","year":"2001","unstructured":"Heijckmann CA, Menheere PP, Sels J-PJ, Beuls EA, Wolffenbuttel BH (2001) Clinical experience with Sandostatin LAR\u00ae in patients with acromegaly. Neth J Med 59(6):286\u2013291","journal-title":"Neth J Med"},{"issue":"3","key":"10304_CR105","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.yfrne.2013.07.005","volume":"34","author":"M Theodoropoulou","year":"2013","unstructured":"Theodoropoulou M, Stalla GK (2013) Somatostatin receptors: from signaling to clinical practice. Front Neuroendocr 34(3):228\u2013252","journal-title":"Front Neuroendocr"},{"issue":"12","key":"10304_CR106","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/annonc\/mdl105","volume":"17","author":"C Susini","year":"2006","unstructured":"Susini C, Buscail L (2006) Rationale for the use of somatostatin analogs as antitumor agents. Ann Oncol 17(12):1733\u20131742","journal-title":"Ann Oncol"},{"issue":"2","key":"10304_CR107","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1210\/clinem\/dgab726","volume":"107","author":"MR Gadelha","year":"2022","unstructured":"Gadelha MR, Wildemberg LE, Kasuki L (2022) The future of somatostatin receptor ligands in acromegaly. J Clin Endocrinol Metabolism 107(2):297\u2013308","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"11","key":"10304_CR108","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0024-3205(82)90087-X","volume":"31","author":"W Bauer","year":"1982","unstructured":"Bauer W, Briner U, Doepfner W, Haller R, Huguenin R, Marbach P et al (1982) SMS 201\u2013995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 31(11):1133\u20131140","journal-title":"Life Sci"},{"issue":"17","key":"10304_CR109","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1517\/14656566.2013.847090","volume":"14","author":"A Giustina","year":"2013","unstructured":"Giustina A, Karamouzis I, Patelli I, Mazziotti G (2013) Octreotide for acromegaly treatment: a reappraisal. Expert Opin Pharmacother 14(17):2433\u20132447","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"10304_CR110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/frne.1999.0183","volume":"20","author":"YC Patel","year":"1999","unstructured":"Patel YC (1999) Somatostatin and its receptor family. Front Neuroendocr 20(3):157\u2013198","journal-title":"Front Neuroendocr"},{"key":"10304_CR111","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1007\/s11095-014-1303-9","volume":"31","author":"S Tuvia","year":"2014","unstructured":"Tuvia S, Pelled D, Marom K, Salama P, Levin-Arama M, Karmeli I et al (2014) A novel suspension formulation enhances intestinal absorption of macromolecules via transient and reversible transport mechanisms. Pharm Res 31:2010\u20132021","journal-title":"Pharm Res"},{"issue":"10","key":"10304_CR112","doi-asserted-by":"crossref","first-page":"e3785","DOI":"10.1210\/clinem\/dgaa526","volume":"105","author":"SL Samson","year":"2020","unstructured":"Samson SL, Nachtigall LB, Fleseriu M, Gordon MB, Bolanowski M, Labadzhyan A et al (2020) Maintenance of acromegaly control in patients switching from injectable somatostatin receptor ligands to oral octreotide. J Clin Endocrinol Metabolism 105(10):e3785\u2013e97","journal-title":"J Clin Endocrinol Metabolism"},{"key":"10304_CR113","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1590\/S0004-27302011000800009","volume":"55","author":"FM Souza","year":"2011","unstructured":"Souza FM, Collett-Solberg PF (2011) Adverse effects of growth hormone replacement therapy in children. Arquivos Brasileiros De Endocrinologia Metabologia 55:559\u2013565","journal-title":"Arquivos Brasileiros De Endocrinologia Metabologia"},{"key":"10304_CR114","doi-asserted-by":"crossref","first-page":"608","DOI":"10.20945\/2359-3997000000191","volume":"63","author":"GA Vasques","year":"2020","unstructured":"Vasques GA, Andrade NL, Correa FA, Jorge AA (2020) Update on new GH-IGF axis genetic defects. Archives Endocrinol Metabolism 63:608\u2013617","journal-title":"Archives Endocrinol Metabolism"},{"issue":"02","key":"10304_CR115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-0043-117897","volume":"68","author":"ZS Aghili","year":"2018","unstructured":"Aghili ZS, Zarkesh-Esfahani SH (2018) Taguchi experimental design for optimization of recombinant human growth hormone production in CHO cell lines and comparing its biological activity with prokaryotic growth hormone. Drug Res 68(02):80\u201388","journal-title":"Drug Res"},{"issue":"18","key":"10304_CR116","doi-asserted-by":"crossref","first-page":"10169","DOI":"10.3390\/ijms251810169","volume":"25","author":"A Kucharska","year":"2024","unstructured":"Kucharska A, Witkowska-S\u0119dek E, Erazmus M, Artemniak-Wojtowicz D, Krajewska M, Pyr\u017cak B (2024) The effects of growth hormone treatment beyond Growth Promotion in patients with genetic syndromes: a systematic review of the literature. Int J Mol Sci 25(18):10169","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10304_CR117","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/cen.12968","volume":"84","author":"J De Schepper","year":"2016","unstructured":"De Schepper J, Vanderfaeillie J, Mullis PE, Rooman R, Robertson A, Dilleen M et al (2016) A 2-year multicentre, open\u2010label, randomized, controlled study of growth hormone (Genotropin\u00ae) treatment in very young children born small for gestational age: early growth and neurodevelopment (EGN) study. Clin Endocrinol 84(3):353\u2013360","journal-title":"Clin Endocrinol"},{"issue":"11","key":"10304_CR118","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.4158\/GL-2019-0405","volume":"25","author":"KC Yuen","year":"2019","unstructured":"Yuen KC, Biller BM, Radovick S, Carmichael JD, Jasim S, Pantalone KM et al (2019) American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care. Endocr Pract 25(11):1191\u20131232","journal-title":"Endocr Pract"},{"issue":"9","key":"10304_CR119","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41581-019-0161-4","volume":"15","author":"J Drube","year":"2019","unstructured":"Drube J, Wan M, Bonthuis M, W\u00fchl E, Bacchetta J, Santos F et al (2019) Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease. Nat Rev Nephrol 15(9):577\u2013589","journal-title":"Nat Rev Nephrol"},{"key":"10304_CR120","doi-asserted-by":"crossref","unstructured":"Maciel J, Dias D, Cavaco D, Donato S, Pereira M, Sim\u00f5es-Pereira J (2021) Growth hormone deficiency and other endocrinopathies after childhood brain tumors: results from a close follow-up in a cohort of 242 patients. J Endocrinol Investig.:1\u20138","DOI":"10.1007\/s40618-021-01541-4"},{"key":"10304_CR121","unstructured":"CADTH Common Drug Reviews (2014) Somatropin (Genotropin) (015\u00a0mg\/day to 03\u00a0mg\/day): Replacement of Endogenous Growth Hormone in Adults with Growth Hormone Deficiency. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health Copyright \u00a9 CADTH 2014"},{"key":"10304_CR122","doi-asserted-by":"crossref","first-page":"592","DOI":"10.20945\/2359-3997000000189","volume":"63","author":"CC van Bunderen","year":"2020","unstructured":"van Bunderen CC, Glad C, Johannsson G, Olsson DS (2020) Personalized approach to growth hormone replacement in adults. Archives Endocrinol Metabolism 63:592\u2013600","journal-title":"Archives Endocrinol Metabolism"},{"issue":"6","key":"10304_CR123","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/joim.13382","volume":"290","author":"G Johannsson","year":"2021","unstructured":"Johannsson G, Ragnarsson O (2021) Growth hormone deficiency in adults with hypopituitarism\u2014what are the risks and can they be eliminated by therapy? J Intern Med 290(6):1180\u20131193","journal-title":"J Intern Med"},{"issue":"10","key":"10304_CR124","doi-asserted-by":"crossref","first-page":"e4238","DOI":"10.1210\/clinem\/dgac307","volume":"107","author":"S Melmed","year":"2022","unstructured":"Melmed S (2022) Is GH replacement for adult GH Deficiency Safe? J Clin Endocrinol Metabolism 107(10):e4238\u2013e9","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"5","key":"10304_CR125","doi-asserted-by":"crossref","first-page":"468","DOI":"10.5603\/EP.a2018.0054","volume":"69","author":"A Lewi\u0144ski","year":"2018","unstructured":"Lewi\u0144ski A, Smyczy\u0144ska J, Stawerska R, Hilczer M, Stasiak M, Bednarczuk T et al (2018) National program of severe growth hormone deficiency treatment in adults and adolescents after completion of growth promoting therapy. Endokrynologia Polska 69(5):468\u2013524","journal-title":"Endokrynologia Polska"},{"issue":"3","key":"10304_CR126","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000524600","volume":"95","author":"R Horikawa","year":"2022","unstructured":"Horikawa R, Tanaka T, Hasegawa Y, Yorifuji T, Ng D, Rosenfeld RG et al (2022) Efficacy and safety of once-weekly somatrogon compared with once-daily somatropin (Genotropin\u00ae) in Japanese children with pediatric growth hormone deficiency: results from a randomized phase 3 study. Hormone Res Paediatrics 95(3):275\u2013285","journal-title":"Hormone Res Paediatrics"},{"issue":"3","key":"10304_CR127","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1515\/jpem-2022-0359","volume":"36","author":"Z Zadik","year":"2023","unstructured":"Zadik Z, Zelinska N, Iotova V, Skorodok Y, Malievsky O, Mauras N et al (2023) An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment. J Pediatr Endocrinol Metab 36(3):261\u2013269","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"20","key":"10304_CR128","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.3390\/jcm13206079","volume":"13","author":"LS Aversa","year":"2024","unstructured":"Aversa LS, Cuboni D, Grottoli S, Ghigo E, Gasco V (2024) A 2024 update on growth hormone Deficiency Syndrome in adults: from guidelines to Real Life. J Clin Med 13(20):6079","journal-title":"J Clin Med"},{"issue":"5","key":"10304_CR129","doi-asserted-by":"crossref","first-page":"R217","DOI":"10.1530\/EJE-16-0962","volume":"176","author":"A Garrahy","year":"2017","unstructured":"Garrahy A, Sherlock M, Thompson CJ (2017) MANAGEMENT OF ENDOCRINE DISEASE: neuroendocrine surveillance and management of neurosurgical patients. Eur J Endocrinol 176(5):R217\u2013R33","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10304_CR130","first-page":"129","volume":"82","author":"Y Janssen","year":"1997","unstructured":"Janssen Y, Frolich M, Roelfsema F (1997) A low starting dose of genotropin in growth hormone-deficient adults. J Clin Endocrinol Metabolism 82(1):129\u2013135","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"9","key":"10304_CR131","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/nm1610","volume":"13","author":"IR Wilkinson","year":"2007","unstructured":"Wilkinson IR, Ferrandis E, Artymiuk PJ, Teillot M, Soulard C, Touvay C et al (2007) A ligand-receptor fusion of growth hormone forms a dimer and is a potent long-acting agonist. Nat Med 13(9):1108\u20131113","journal-title":"Nat Med"},{"issue":"3","key":"10304_CR132","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/cen.12240","volume":"79","author":"P Cawley","year":"2013","unstructured":"Cawley P, Wilkinson I, Ross RJ (2013) Developing long-acting growth hormone formulations. Clin Endocrinol 79(3):305\u2013309","journal-title":"Clin Endocrinol"},{"issue":"5","key":"10304_CR133","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrendo.2018.22","volume":"14","author":"MB Ranke","year":"2018","unstructured":"Ranke MB, Wit JM (2018) Growth hormone\u2014past, present and future. Nat Reviews Endocrinol 14(5):285\u2013300","journal-title":"Nat Reviews Endocrinol"},{"issue":"12","key":"10304_CR134","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1080\/14740338.2020.1839410","volume":"19","author":"C H\u00f6ybye","year":"2020","unstructured":"H\u00f6ybye C, Beck-Peccoz P, Simsek S, Zabransky M, Zouater H, Stalla G et al (2020) Safety of current recombinant human growth hormone treatments for adults with growth hormone deficiency and unmet needs. Exp Opin Drug Saf 19(12):1539\u20131548","journal-title":"Exp Opin Drug Saf"},{"issue":"4","key":"10304_CR135","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2337\/dc11-1833","volume":"35","author":"N Friedrich","year":"2012","unstructured":"Friedrich N, Thuesen B, J\u00f8rgensen T, Juul A, Spielhagen C, Wallaschofksi H et al (2012) The association between IGF-I and insulin resistance: a general population study in Danish adults. Diabetes Care 35(4):768\u2013773","journal-title":"Diabetes Care"},{"issue":"9216","key":"10304_CR136","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(05)73137-8","volume":"355","author":"J Monson","year":"2000","unstructured":"Monson J, Bengtsson B-\u00c5, Abs R, Feldt-Rasmussen U, W\u00fcster C (2000) Can growth hormone therapy cause diabetes? Lancet 355(9216):1728","journal-title":"Lancet"},{"key":"10304_CR137","doi-asserted-by":"crossref","unstructured":"Turchyna S, Nikitina L, Varodova O, Kalmykova Y, Kalmykov S (2022) Functional state of the GH\/IGF-1 system in adolescents with type 1 diabetes mellitus. Physical rehabilitation and recreational health technologies (2016\u20132022). 7(4):171\u2013178","DOI":"10.15391\/prrht.2022-7(4).28"},{"key":"10304_CR138","unstructured":"De Sanctis V, Soliman A, Daar S, Tzoulis P, Yassin MA, Di Maio S et al (2022) Insulin-like growth factor-1 (IGF-1) and glucose dysregulation in young adult patients with \u03b2-thalassemia major: causality or potential link? Acta Bio Medica: Atenei Parmensis.;93(6)"},{"key":"10304_CR139","doi-asserted-by":"crossref","first-page":"210375","DOI":"10.3389\/fendo.2016.00129","volume":"7","author":"LE Fridlyand","year":"2016","unstructured":"Fridlyand LE, Tamarina NA, Schally AV, Philipson LH (2016) Growth hormone-releasing hormone in diabetes. Front Endocrinol 7:210375","journal-title":"Front Endocrinol"},{"issue":"2","key":"10304_CR140","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/cen.13256","volume":"86","author":"MM Weber","year":"2017","unstructured":"Weber MM, Biller BM, Pedersen BT, Pournara E, Christiansen JS, H\u00f6ybye C (2017) The effect of growth hormone (GH) replacement on blood glucose homeostasis in adult nondiabetic patients with GH deficiency: real-life data from the NordiNet\u00ae International Outcome Study. Clin Endocrinol 86(2):192\u2013198","journal-title":"Clin Endocrinol"},{"issue":"7","key":"10304_CR141","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1210\/jc.2011-0448","volume":"96","author":"AF Attanasio","year":"2011","unstructured":"Attanasio AF, Jung H, Mo D, Chanson P, Bouillon R, Ho KK et al (2011) Prevalence and incidence of diabetes mellitus in adult patients on growth hormone replacement for growth hormone deficiency: a surveillance database analysis. J Clin Endocrinol Metabolism 96(7):2255\u20132261","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"5","key":"10304_CR142","doi-asserted-by":"crossref","first-page":"696","DOI":"10.4103\/ijem.IJEM_579_17","volume":"22","author":"S Kalra","year":"2018","unstructured":"Kalra S, Jena BN, Yeravdekar R (2018) Emotional and psychological needs of people with diabetes. Indian J Endocrinol Metabol 22(5):696\u2013704","journal-title":"Indian J Endocrinol Metabol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10304-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10304-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10304-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:33:28Z","timestamp":1766853208000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10304-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":142,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10304"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10304-w","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"24 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have read and have abided by the statement of ethical standards for manuscripts submitted to the journal. This article does not contain any studies with human participants or animals performed by any of the authors. We declare that the submitted manuscript does not contain previously published materials and are not under consideration for publication elsewhere. All the authors have made a substantial contribution to conception and design, or collection, analysis and interpretation of data, writing or revising the manuscript, or providing guidance on the research\u2019s execution.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"202"}}